Next Article in Journal
Valine Radiolysis by H+, He+, N+, and S15+ MeV Ions
Next Article in Special Issue
2-(3-Hydroxy-5-phosphonooxymethyl-2-methyl-4-pyridyl)-1,3-thiazolidine-4-carboxylic Acid, Novel Metabolite of Pyridoxal 5′-Phosphate and Cysteine Is Present in Human Plasma—Chromatographic Investigations
Previous Article in Journal
Pravastatin Alleviates Radiation Proctitis by Regulating Thrombomodulin in Irradiated Endothelial Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 21
Issue 5
10.3390/ijms21051899
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Functional Consequences of Low Activity of Transport System A for Neutral Amino Acids in Human Bone Marrow Mesenchymal Stem Cells

by
Martina Chiu
1,*,†,
Giuseppe Taurino
1,†,
Massimiliano G. Bianchi
1,
Erica Dander
2,
Alessandra Fallati
2,
Nicola Giuliani
1,
Giovanna D’Amico
2 and
Ovidio Bussolati
1,*
1
Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy
2
Centro Ricerca Tettamanti, Pediatric Dept., University of Milano-Bicocca, Fondazione MBBM, 20900 Monza, Italy
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Int. J. Mol. Sci. 2020, 21(5), 1899; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21051899
Submission received: 4 February 2020 / Revised: 7 March 2020 / Accepted: 9 March 2020 / Published: 10 March 2020
(This article belongs to the Special Issue Amino Acids Transport and Metabolism 3.0)
Browse Figures
Versions Notes

Abstract

:
In cultured human fibroblasts, SNAT transporters (System A) account for the accumulation of non-essential neutral amino acids, are adaptively up-regulated upon amino acid deprivation and play a major role in cell volume recovery upon hypertonic stress. No information is instead available on the expression and activity of SNAT transporters in human bone marrow mesenchymal stromal cells (MSC), although they are increasingly investigated for their staminal and immunomodulatory properties and used for several therapeutic applications. The uptake of glutamine and proline, two substrates of SNAT1 and SNAT2 transporters, was measured in primary human MSC and an MSC line. The amino acid analogue MeAIB, a specific substrate of these carriers, has been used to selectively inhibit SNAT-dependent transport of glutamine and, through its sodium-dependent transport, as an indicator of SNAT1/2 activity. SNAT1/2 expression and localization were assessed with RT-PCR and confocal microscopy, respectively. Cell volume was assessed from urea distribution space. In all these experiments, primary human fibroblasts were used as the positive control for SNAT expression and activity. Compared with fibroblasts, MSC have a lower SNAT1 expression and hardly detectable membrane localization of both SNAT1 and SNAT2. Moreover, they exhibit no sodium-dependent MeAIB uptake or MeAIB-inhibitable glutamine transport, and exhibit a lower ability to accumulate glutamine and proline than fibroblasts. MSC exhibited an only marginal increase in MeAIB transport upon amino acid starvation and did not recover cell volume after hypertonic stress. In conclusion, the activity of SNAT transporters is low in human MSC. MSC adaptation to amino acid shortage is expected to rely on intracellular synthesis, given the absence of an effective up-regulation of the SNAT transporters.

1. Introduction

Bone marrow mesenchymal stem cells (MSC) are self-renewable, multipotent cells capable of multi-lineage differentiation into adipocytes, chondrocytes or osteoblasts [1], and, hence, widely used for different applications in regenerative medicine [2,3]. Moreover, MSC secrete a variety of soluble mediators that influence various types of immune cells and have distinctive immunomodulatory properties that widen the range of their potential therapeutic applications [4,5]. Although metabolism is considered an important determinant of MSC properties, their metabolic features are yet to be completely defined [6].
In particular, metabolic features may be of particular relevance for the nutritional support that MSC can provide to other cells of the microenvironment. For example, in the case of Acute Lymphoblastic Leukemia (ALL), MSC produce and secrete asparagine (Asn) to support the growth of leukemic blasts, which are auxotroph for Asn [7,8]. Asn synthesis through asparagine synthetase requires glutamine (Gln) as the obliged nitrogen donor [9]. Thus, the nutritional support of ALL blasts by MSC is only possible if Gln availability is adequate.
Actually, the metabolic role of Gln far exceeds its participation in the synthesis of asparagine since the amino acid is needed for the synthesis of nucleotides and, through glutamate, of other non-essential amino acids. Moreover, in several types of normal and cancer cells [10], Gln also plays an anaplerotic role in sustaining cell energetics, providing carbon moieties for the TCA cycle.
Gln is the most abundant amino acid in human plasma (about 0.6 mM). However, even at this relatively high concentration, a fast influx of Gln, given its hydrophilicity, relies on the activity of transporters. Indeed, at least four families of carriers are involved in Gln uptake in mammalian cells, namely SLC1, SLC6, SLC7 and SLC38. While the exchange transporter ASCT2, coded by SLC1A5, has been widely found overexpressed in numerous cancer cell models, the so called System A and System N transporters, members of the SLC38 family are considered the principal unidirectional transporters for the amino acid [11]. The sodium-dependent System A transporters play important physiological functions [12]. SNAT1 and SNAT2, the most widely expressed and deeply investigated members of this group, are secondary active transporters able to build high transmembrane gradients of their substrates. System A transporters, but not other sodium-dependent amino acid carriers, are characterized by their tolerance for N-alkyl substitutions. For this reason, the analogue α-methylaminoisobutyric acid (MeAIB) is considered a paradigm substrate to specifically discriminate System A carrier activity [13,14,15,16,17]. Indeed, MeAIB is actively transported into SNAT1/2-positive cells and, therefore, its sodium-dependent influx can be considered an indicator of SNAT transport activity. Moreover, it is a competitive inhibitor of other substrates of SNAT1/2 and, at high concentrations, suppresses their SNAT-dependent influx, thus allowing the evaluation of SNAT1/2 contribution to the transport of substrates, such as Gln, that interact with multiple types of carriers.
No attempt to investigate Gln uptake or the expression and activity of SNAT transporters in MSC has been made yet. Here we shown that, compared with human fibroblasts, when cultured in standard growth medium, human bone marrow-derived MSC are endowed with lower activity of System A transporters, which is associated with a reduced Gln cell content and impaired ability to recover cell volume upon hypertonic stress.

2. Results

2.1. MeAIB Does Not Inhibit Glutamine Transport in Human Mesenchymal Stem Cells

Firstly, we characterized Glutamine (Gln) uptake in a strain of human primary MSC, in a human immortalized MSC line (hTERT-MSC) and in a widely employed strain of human diploid fibroblasts (IMR-90). As shown in Figure 1a, in all the cell types the Na+-dependent uptake of Gln was completely suppressed by a high concentration of threonine (Thr), a preferential substrate of ASCT2 [18] that also interacts at low affinity with System A [19], while a small quote of uptake was inhibited by histidine (His), a substrate of System N [20] in primary MSC and in fibroblasts. MeAIB, a specific substrate of the System A SNAT transporters [15,21], lowered Gln uptake only in fibroblasts, but neither in MSC nor in hTERT-MSC (Figure 1a). Lack of a MeAIB-inhibitable component of Gln uptake was confirmed also in the other three strains of primary MSC [22]. Despite MSC showing a higher initial Gln influx than fibroblast, the intracellular Gln content, measured in cells maintained in standard growth medium, was lower in either primary MSC or in hTERT-MSC than in IMR-90 fibroblasts (Figure 1b). This result is consistent with the absence of System A activity and suggest that in MSC Gln uptake mainly occurs through the activity of an ASCT2 exchanger transporter.

2.2. Mesenchymal Stem Cells Have a Low Expression of the System A Transporters

The expression of SNAT1 and SNAT2, two System A transporters involved in Gln uptake, was evaluated in the three cell types. The expression of SLC38A1, encoding for SNAT1, was 50% lower in primary MSC than in IMR-90 fibroblasts and hardly detectable in hTERT-MSC (Figure 2a), while SCL38A2 expression, the gene encoding for SNAT2, was comparable in primary MSC and IMR-90 fibroblasts (Figure 2b), and lower in hTERT-MSC.
It is known that the expression of SNAT transporters is regulated at different levels in several experimental conditions [12]. In particular, a distinctive feature of the SNAT2 transporter is the so-called adaptive regulation, which consists of an increase in transporter expression and activity upon amino acid starvation. Indeed, after 4 h of amino acid starvation, the expression of SNAT2 was upregulated in all the cell types tested with the highest expression in IMR-90 fibroblasts (Figure 2b), while SNAT1 expression showed a modest increase only in IMR-90 in the same conditions (Figure 2a).
Since adaptive regulation can occur at different levels, including the targeting of the transporters on the cell membrane [23], the localization of SNAT1 and SNAT2 was monitored by means of confocal microscopy, either in cells maintained in complete growth medium or starved for 4 h in the absence of amino acids, a condition associated with enhanced membrane expression and transport activity [23]. As shown in Figure 3a, in cells maintained in complete growth medium, membrane localization of both SNAT1 and SNAT2 was evident in IMR-90 cells, while only a diffuse intracellular signal is present in MSC and hTERT-MSC. Moreover, upon amino acid starvation, both SNAT1 and SNAT2 exhibited an increased membrane signal in IMR-90 cells, while the increase was barely detectable in primary MSC and not detected at all in hTERT-MSC (Figure 3b).

2.3. Mesenchymal Stem Cells Do Not Exhibit an Increase in System A Activity upon Amino Acid Starvation

To evaluate the functional outcomes of the different membrane expression of SNAT transporters, the uptake of their specific substrate MeAIB was evaluated in a panel of human primary MSC, in immortalized hTERT-MSC and in human fibroblasts. As expected, in non-starved cells, only IMR-90 fibroblasts displayed a Na+-dependent MeAIB uptake (Figure 4a). Upon 4 h of amino acid starvation, a small Na+-dependent component of MeAIB uptake emerged in primary MSC but not in hTERT-MSC (Figure 4b). However, while a clear-cut increment of the Na+-dependent component of MeAIB uptake was detectable after 4 h of starvation in fibroblasts, this effect was absent or marginal in the MSC tested (Figure 4c). Consistently, only for human fibroblasts MeAIB uptake was larger in the amino acid-starved cells than in the control cells.

2.4. Mesenchymal Stem Cells Do Not Show a Sodium-Dependent Proline Accumulation

Given the presence of a secondary amine in its structure, proline (Pro) cannot interact with carriers for amino acids other than System A transporters [16] and the tissue-specific SIT1 [16,24]. To further confirm the absence of System A transport activity in MSC, the time course of Pro uptake was compared in human fibroblasts and MSC. A clear-cut Na+-dependent uptake of Pro was already evident in fibroblasts after 5 min of incubation (Figure 5a) and steadily increased up to 30 min, while, in the absence of sodium, intracellular Pro reached a plateau at 15 min, at levels less than halved compared to cells maintained in the presence of the cation. In contrast, in both primary and immortalized MSC, no Na+-dependent accumulation of Pro was detected (Figure 5b,c), and the intracellular levels of the amino acid were comparable in the absence and in the presence of the cation. Moreover, MSC exhibited only a limited increase in intracellular levels of Pro from 15 to 30 min of uptake.

2.5. Mesenchymal Stem Cells Do Not Recover Cell Volume after Hypertonic Stress

In cultured human fibroblasts [25], as well as in other human cell models [26,27,28], System A plays a pivotal role in the maintenance of cell volume under hypertonic conditions [23]. In the experiment shown in Figure 6, fibroblasts and MSC were incubated for 3 h in isotonic (300 mOsm) or hypertonic medium (450 mOsm). Then, the intracellular fluid, as a proxy of cell volume, was measured by urea distribution [29]. No difference in urea distribution was detected in IMR-90 fibroblasts, indicating an effective and complete recovery of cell volume. On the contrary, upon hypertonic stress, both primary and immortalized MSC had significantly smaller values of urea distribution space than their counterparts maintained under isotonic conditions, indicating a limited or null ability to counteract volume perturbation.

3. Discussion

In this report we show that bone-marrow-derived mesenchymal stem cells have a low-to-absent expression and activity of the SNAT1 and SNAT2 System A transporters, as indicated by the sodium-dependent uptake of the SNAT1/2-characterizing substrate α-methylaminoisobutyric acid (MeAIB), which is much lower than in cultured human fibroblasts. This metabolic peculiarity is associated with several functional consequences.
Glutamine is the most abundant amino acid in human plasma and play several tissue-specific functions, besides a central role in cell metabolism. The amino acid can be transported into the cells through the activity of several transporters, both sodium-dependent, such as ASCT2 and SNAT1/2, and sodium-independent, such as those of the LAT family. However, while ASCT2 and LAT are exchange transporters, SNAT1 and SNAT2 are concentrative carriers. Thus, the activity of SNAT transporters is the major determinant of intracellular glutamine levels. In turn, the intracellular glutamine concentration determines the overall size of the intracellular amino acid pool, given that it energizes the entry of essential amino acids through exchange systems (ASCT2 or LAT) [30,31], or indirectly replenishes the cysteine pool by providing glutamate that favors cystine uptake through the SLC7A11 antiporter [32]. Moreover, regulating the cell content of amino acids, SNAT transporters account for the ability of several mesenchymal cell types to recover cell volume under hypertonic conditions [25,26,27,28,33]. Upon amino acid starvation, SNAT2 [23,34] undergoes a marked up-regulation, which is an integral part of the cell response to nutritional stress [35]. As a consequence of the low expression of the SNAT transporters, these characteristic operational features of System A are hindered or even suppressed in MSC, with a blunted increase in substrate uptake upon amino acid starvation (Figure 4), a reduced ability to counteract cell shrinkage upon hypertonic stress (Figure 6) and lowered intracellular levels of glutamine at the steady state (Figure 1b).
These features are present in several strains of primary MSC from healthy donors but also in a TERT-immortalized line derived from these cells, which is endowed with the lowest expression levels of SNAT1 and SNAT2 (Figure 2a,b) among the cell types tested and, consistently, does not exhibit sodium-dependent uptake of MeAIB, even after a 4 h starvation, and any recovery of cell volume upon hypertonic incubation. Although other transporters, such as ASCT2, are expressed (results not shown) and operative (Figure 1a), they do not appear to energize amino acid accumulation with the same mechanism used by SNAT transporters and may be less efficient (see Figure 5). Thus, it is expected that, upon conditions of nutritional stress, these cells would only rely on the intracellular synthesis of substrates of system A, most of which are non-essential amino acids, without exploiting any enhancement of transport capability. This peculiarity would point to MSC as possible providers of amino acids for other cell types in a tissue undergoing amino acid restriction.
Proline (Pro) is a non-essential amino acid of particular relevance in mesenchymal cells, since it is needed for collagen synthesis and may play regulatory functions [36,37,38,39]. Due to its structural features, proline is a good substrate of SNAT transporters, which tolerate N-alkyl substitutions, but not of other sodium-dependent transporters, with the remarkable exception of the sodium- and chloride-dependent “IMINO” transporter SIT1 (SLC6A20, [24]) that, however, has a more restricted tissue-specific and development-dependent expression than SNAT transporters [40]. Limited expression and activity of SNAT transporters are associated with a reduced ability of MSC to accumulate proline from the extracellular medium (Figure 5). Due to the regulatory role of the amino acid [30,31,32,33], it would be interesting to ascertain whether changes in proline metabolism or transport occur during MSC differentiation. However, it should be noted that the amino acid is still accumulated in MSC as well as in human fibroblasts maintained in sodium-free conditions, although at reduced levels compared with fibroblasts maintained in the presence of sodium. Taking into account the values of urea distribution space provided in Figure 6, it is possible to calculate that the proline trans-membrane gradient is more than 10 in MSC and in human fibroblasts incubated without sodium, and more than 20 in fibroblasts in the presence of sodium. While the gradient measured in the presence of sodium is consistent with System A operation, the presence of a clear-cut proline gradient in the absence of sodium raises the possibility that an active, sodium-independent transporter, tentatively attributable to a member of the SLC36 family, is operative in MSC and in fibroblasts. Further experiments are needed to verify this hypothesis.
In conclusion, the results presented in this report offer a demonstration of the functional consequences of a lack of SNAT transporters in primary human cells. Moreover, they extend our knowledge on the metabolic features of MSC, possibly pointing to their role as amino acid providers under conditions of nutritional stress.

4. Materials and Methods

4.1. Cell Culture

Bone-marrow mesenchymal stem cells (MSC) were isolated as described previously [41] from healthy donors. Informed, written consent approved by the local ethical committee was obtained in all cases. hTERT-MSC were kindly provided by Dr. D. Campana (S.Jude Hospital, Memphis, TN, USA). IMR-90 lung human fetal fibroblasts were obtained from the Cell Bank of the IZSLER (Brescia, Italy). Cells, seeded at 3 × 103 cells/cm2, were grown in low-glucose Dulbecco’s modified medium (DMEM, EuroClone) supplemented with 2 mM Gln, 10% fetal bovine serum (FBS) and antibiotics (100 U/mL penicillin and 100 μg/mL streptomycin). At Passage 3 MSC were screened for the expression of CD73, CD90, CD105, CD14 and CD34 by flow cytometry and for their ability to differentiate into osteoblasts and adipocytes. Cells were not used for more than 7 passages.

4.2. RT-PCR Analysis

A total of 1 μg of total RNA, isolated with the GeneJET RNA Purification Kit (Thermo Fisher Scientific, Waltham, MA, USA), was reverse transcribed with the RevertAid RT Reverse Transcription Kit (Thermo Fisher Scientific) following the manufacturer’s instruction. For real time PCR (35 cycles), cDNA was amplified with PowerUp™ SYBR™ Green Master Mix (Applied Biosystem, Foster City, CA, USA) along with the following primers (5 pmol each): RPL-15 (for 5′-GCAGCCATCAGGTAAGCCAAG-3′, rev 5′-AGCGGACCCTCAGAAGAAAGC-3′); SLC38A1 (for 5′-CACCACAGGGAAGTTCGTAATC-3′, rev 5′-CGTACCAGGCTGAAAATGTCTC-3′); SLC38A2 ( for 5′-ATGAAGAAGGCCGAAATGGGA-3′, rev 5′-TGCTTGGTGGGGTAGGAGTAG-3′). Quantitative PCR was performed in a StepOneTM Real-Time PCR System (Applied Biosystems, Waltham, MA, USA). Each cycle consisted of a denaturation step at 95 °C for 30 s, followed by separate annealing (30 s, 55–58 °C) and extension (30 s, 72 °C) steps. Fluorescence was monitored at the end of each extension step. A no-template, no-reverse transcriptase control was included in each experiment. At the end of the amplification cycles a melting curve analysis was added. Data analysis was made according to the Relative Standard Curve Method [42]. Expression data were normalized to RPL-15 mRNA expression.

4.3. Amino Acid Uptake

For the Gln and α-methylaminoisobutyric acid (MeAIB) influx analysis [43], 8 × 103 cells/well, seeded in 96-well multi-dish plates (Falcon, Becton Dickinson Biosciences, Franklin Lakes, NJ, USA) 48 h earlier, were incubated for 90 min in Earle’s Balanced Salt Solution (EBSS, NaCl 117 mM, Tris-HCl 26 mM; KCl 5.3 mM, CaCl2 1.8 mM, MgSO4·7H2O 0.81 mM, choline phosphate 0.9 mM, glucose 5.5, supplemented with 0.02% Phenol Red, adjusted at pH 7.4). This pre-incubation was aimed to minimize the trans-effects that would artificially increase the contribution of the exchange systems to transport. Cells were then rinsed with 200 μL of Na+-free EBSS, where NaCl was replaced by the chloride salt of N-methyl-d-glucamine. For Gln transport, cells were incubated for 1 min at pH 7.4 in EBSS or in a Na+-free EBSS, supplemented with L-(3,4-3H(N))-Gln (10 μCi/mL, PerkinElmer, Groningen, The Netherlands). For the discrimination of sodium-dependent transporters, the Gln influx was measured in the absence or in the presence of MeAIB (10 mM), threonine (Thr, 5 mM) or histidine (His, 5 mM), as preferential inhibitors of System A, ASCT2 or System N transporters, respectively, as described in [43].
For Pro accumulation, cells were incubated for 90 min in EBSS, rinsed with 200 μL of Na+-free EBSS and incubated at pH 7.4 in EBSS or in Na+-free EBSS supplemented with L-(2,3,4,5-3H)-Pro (15 μCi/mL, PerkinElmer).
For MeAIB initial influx, cells were incubated for 90 min or 4 h in EBSS, rinsed with 200 μL of Na+-free EBSS and incubated at pH 7.4 in EBSS or in a Na+-free EBSS supplemented with α-(1-14C)-MeAIB (2.5 μCi/mL, PerkinElmer).
In all cases, after the chosen uptake times, cells were washed with ice-cold urea (300 mM) to stop amino acid trans-membrane fluxes. Cells were then extracted with 50 μL of cold absolute ethanol. The extracts were mixed with 200 μL of scintillation fluid and counted with a scintillation spectrometer (Microbeta2, PerkinElmer, Milan, Italy). Influx data were expressed as pmol/mg prot/min while accumulation data were expressed as nmol/mg of protein.

4.4. Immunofluorescence

Cells were seeded on 4-chamber CultureSlides (Falcon, Becton & Dickinson Company, San Jose, CA, USA) at a density of 12.5 × 103 cells/cm2. At the end of the treatments, cells were rinsed twice in PBS and fixed for 10 min in 3.7% paraformaldehyde in PBS. After two further rinses, cells were permeabilized with 0.1% Triton in PBS for 7 min. Cells were incubated for 1 h in blocking solution (5% of BSA, 10% of goat serum, and 0.3 M glycine in PBS), and then incubated at 4 °C overnight with anti-SNAT1 (rabbit, polyclonal, 1:300, Abcam, Cambridge, UK) or anti-SNAT2 (mouse, polyclonal, 1:300, SantaCruz Biotechnology, Dallas, TX, USA). Cells were washed with PBS and stained with Alexa Fluor 633 Phalloidin (Thermo Fisher Scientific) for 30 min. After washing, cells were incubated for 1h with Alexa Fluor 488 anti-mouse IgG and Alexa Fluor 546 anti-rabbit IgG antibodies (Invitrogen, Paisley, UK, 1:400). Cells were observed with a confocal microscope Zeiss® 510 LSM Meta (Carl Zeiss SpA, Arese, Milan, Italy), using an oil 60× objective (NA 1.3).

4.5. Intracellular Gln Content

A total of 1 × 105 cells were seeded in 12-well multi-dish plates (Falcon), and after 24 h the medium was substituted with fresh medium containing 2 mM Gln. After 18 h, cells were washed in ice-cold PBS and cell monolayers were extracted with 300 µL of absolute ethanol. Samples were then lyophilized and suspended in 250 µL of ultra-pure distilled water (Thermo Fisher Scientific). To convert glutamine into glutamate, 10 U/mL of L-asparaginase (from E. chrysanthemi, a gift of Jazz Pharmaceuticals) were added to the samples that were incubated for 2 h at 37 °C. Glutamate was measured with a Glutamate Assay Kit (Abcam), and the glutamine content was obtained subtracting the glutamate content of samples incubated in the absence of l-asparaginase from that of the same samples incubated with the enzyme.

4.6. Cell Volume

A total of 5 × 104 cells were seeded in 24-well multi-dish plates (Falcon). After 24 h, the medium was substituted with complete growth medium (300 mOsm) for isotonic conditions or with DMEM supplemented with 150 mM sucrose for a final osmolality of 450 mOsm for a hypertonic condition. Osmolalities were monitored with a Wescor vapor pressure osmometer. After 3 h, the cell volume was estimated from the distribution space of the urea according to a method previously employed in cultured human fibroblasts [23]. 14C-Urea (10 μCi/mL, 0.5 mM final concentration) was added during the last 10 min of incubations. The experiment was stopped with two rapid washes in ice-cold 300 mM urea in water. Alcohol-soluble pools were extracted with absolute ethanol and added to scintillation fluid to be counted for radioactivity as described in Section 4.4. The results were expressed as μL/mg prot.

4.7. Statistical Analysis

For statistical analysis, two-tailed Student’s t-tests for unpaired data were used. GraphPad Prism 5.0™ was used for all the statistical analyses and p values <0.05 were considered statistically significant.

4.8. Reagents

Serum was obtained from Lonza, Basel, Switzerland. Unless otherwise stated Sigma (Milan, Italy) was the source of all the other chemicals.

Author Contributions

Conceptualization, M.C., G.T. and O.B.; investigation, M.C., G.T., M.G.B., E.D. and A.F.; data curation, M.C. and G.T.; writing—original draft, M.C.; writing—review and editing, M.C., G.T., G.D.A., E.D., N.G. and O.B.; funding acquisition, N.G. and G.D.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research was founded by Associazione Italiana per la Ricerca contro il Cancro (AIRC), IG 2019 n. 23354 with the P.I. Giovanna D’Amico, and IG2017 n. 20299, with P.I. Nicola Giuliani.

Acknowledgments

This work was supported by the University of Parma.Martina Chiu is supported by a fellowship from the Associazione Italiana per la Ricerca sul Cancro (AIRC #19272).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Pittenger, M.F.; Mackay, A.M.; Beck, S.C.; Jaiswal, R.K.; Douglas, R.; Mosca, J.D.; Moorman, M.A.; Simonetti, D.W.; Craig, S.; Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284, 143–147. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Oliveira, J.T.; Mostacada, K.; de Lima, S.; Martinez, A.M. Bone marrow mesenchymal stem cell transplantation for improving nerve regeneration. Int. Rev. Neurobiol. 2013, 108, 59–77. [Google Scholar] [PubMed]
  3. Karamini, A.; Bakopoulou, A.; Andreadis, D.; Gkiouras, K.; Kritis, A. Therapeutic potential of mesenchymal stromal stem cells in rheumatoid arthritis: A systematic review of in vivo studies. Stem Cell Rev. Rep. 2020. [Epub ahead of print]. [Google Scholar] [CrossRef] [PubMed]
  4. Kim, N.; Cho, S.G. Overcoming immunoregulatory plasticity of mesenchymal stem cells for accelerated clinical applications. Int. J. Hematol. 2016, 103, 129–137. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Naji, A.; Eitoku, M.; Favier, B.; Deschaseaux, F.; Rouas-Freiss, N.; Suganuma, N. Biological functions of mesenchymal stem cells and clinical implications. Cell Mol. Life Sci. 2019, 76, 3323–3348. [Google Scholar] [CrossRef]
  6. Yuan, X.; Logan, T.M.; Ma, T. Metabolism in human mesenchymal stromal cells: A missing link between hmsc biomanufacturing and therapy? Front. Immunol. 2019, 10, 977. [Google Scholar] [CrossRef] [Green Version]
  7. Iwamoto, S.; Mihara, K.; Downing, J.R.; Pui, C.H.; Campana, D. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J. Clin. Investig. 2007, 117, 1049–1057. [Google Scholar] [CrossRef]
  8. Ehsanipour, E.A.; Sheng, X.; Behan, J.W.; Wang, X.; Butturini, A.; Avramis, V.I.; Mittelman, S.D. Adipocytes cause leukemia cell resistance to l-asparaginase via release of glutamine. Cancer Res. 2013, 73, 2998–3006. [Google Scholar] [CrossRef] [Green Version]
  9. Chiu, M.; Taurino, G.; Bianchi, M.G.; Kilberg, M.S.; Bussolati, O. Asparagine synthetase in cancer: Beyond acute lymphoblastic leukemia. Front. Oncol. 2019, 9, 1480. [Google Scholar] [CrossRef]
  10. DeBerardinis, R.J.; Cheng, T. Q’s next: The diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 2010, 29, 313–324. [Google Scholar] [CrossRef] [Green Version]
  11. Bhutia, Y.D.; Ganapathy, V. Glutamine transporters in mammalian cells and their functions in physiology and cancer. Biochim. Biophys. Acta 2016, 1863, 2531–2539. [Google Scholar] [CrossRef] [PubMed]
  12. Broer, S. The slc38 family of sodium-amino acid co-transporters. Pflüg. Arch. 2014, 466, 155–172. [Google Scholar] [CrossRef] [PubMed]
  13. Shotwell, M.A.; Jayme, D.W.; Kilberg, M.S.; Oxender, D.L. Neutral amino acid transport systems in chinese hamster ovary cells. J. Biol. Chem. 1981, 256, 5422–5427. [Google Scholar] [PubMed]
  14. Ericsson, A.; Hamark, B.; Jansson, N.; Johansson, B.R.; Powell, T.L.; Jansson, T. Hormonal regulation of glucose and system a amino acid transport in first trimester placental villous fragments. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288, R656–R662. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Christensen, H.N.; Oxender, D.L.; Liang, M.; Vatz, K.A. The use of n-methylation to direct route of mediated transport of amino acids. J. Biol. Chem. 1965, 240, 3609–3616. [Google Scholar]
  16. Mackenzie, B.; Erickson, J.D. Sodium-coupled neutral amino acid (system n/a) transporters of the slc38 gene family. Pflüg. Arch. 2004, 447, 784–795. [Google Scholar] [CrossRef]
  17. Takahashi, Y.; Nishimura, T.; Maruyama, T.; Tomi, M.; Nakashima, E. Contributions of system a subtypes to alpha-methylaminoisobutyric acid uptake by placental microvillous membranes of human and rat. Amino Acids 2017, 49, 795–803. [Google Scholar] [CrossRef]
  18. Foster, A.C.; Farnsworth, J.; Lind, G.E.; Li, Y.X.; Yang, J.Y.; Dang, V.; Penjwini, M.; Viswanath, V.; Staubli, U.; Kavanaugh, M.P. D-serine is a substrate for neutral amino acid transporters asct1/slc1a4 and asct2/slc1a5, and is transported by both subtypes in rat hippocampal astrocyte cultures. PLoS ONE 2016, 11, e0156551. [Google Scholar] [CrossRef]
  19. Bussolati, O.; Rotoli, B.M.; Laris, P.C.; Dall’Asta, V.; Gazzola, G.C. The preferential interaction of l-threonine with transport system asc in cultured human fibroblasts. Biochim. Biophys. Acta 1991, 1070, 305–312. [Google Scholar] [CrossRef]
  20. Chaudhry, F.A.; Reimer, R.J.; Krizaj, D.; Barber, D.; Storm-Mathisen, J.; Copenhagen, D.R.; Edwards, R.H. Molecular analysis of system n suggests novel physiological roles in nitrogen metabolism and synaptic transmission. Cell 1999, 99, 769–780. [Google Scholar] [CrossRef] [Green Version]
  21. Rae, C.; Hare, N.; Bubb, W.A.; McEwan, S.R.; Broer, A.; McQuillan, J.A.; Balcar, V.J.; Conigrave, A.D.; Broer, S. Inhibition of glutamine transport depletes glutamate and gaba neurotransmitter pools: Further evidence for metabolic compartmentation. J. Neurochem. 2003, 85, 503–514. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Chiu, M.; Bussolati, O. Department of Medicine and Surgery, University of Parma: Parma, Italy. 2020; Manuscript in preparation. [Google Scholar]
  23. Franchi-Gazzola, R.; Gaccioli, F.; Bevilacqua, E.; Visigalli, R.; Dall’Asta, V.; Sala, R.; Varoqui, H.; Erickson, J.D.; Gazzola, G.C.; Bussolati, O. The synthesis of snat2 transporters is required for the hypertonic stimulation of system a transport activity. Biochim. Biophys. Acta 2004, 1667, 157–166. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Takanaga, H.; Mackenzie, B.; Suzuki, Y.; Hediger, M.A. Identification of mammalian proline transporter sit1 (slc6a20) with characteristics of classical system imino. J. Biol. Chem. 2005, 280, 8974–8984. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Dall’Asta, V.; Rossi, P.A.; Bussolati, O.; Gazzola, G.C. Response of human fibroblasts to hypertonic stress. Cell shrinkage is counteracted by an enhanced active transport of neutral amino acids. J. Biol. Chem. 1994, 269, 10485–10491. [Google Scholar]
  26. Breborowicz, A.; Polubinska, A.; Oreopoulos, D.G. Changes in volume of peritoneal mesothelial cells exposed to osmotic stress. Perit. Dial. Int. 1999, 19, 119–123. [Google Scholar] [CrossRef]
  27. Dall’Asta, V.; Bussolati, O.; Sala, R.; Parolari, A.; Alamanni, F.; Biglioli, P.; Gazzola, G.C. Amino acids are compatible osmolytes for volume recovery after hypertonic shrinkage in vascular endothelial cells. Am. J. Physiol. 1999, 276, C865–C872. [Google Scholar] [CrossRef]
  28. Maallem, S.; Mutin, M.; Gonzalez-Gonzalez, I.M.; Zafra, F.; Tappaz, M.L. Selective tonicity-induced expression of the neutral amino-acid transporter snat2 in oligodendrocytes in rat brain following systemic hypertonicity. Neuroscience 2008, 153, 95–107. [Google Scholar] [CrossRef]
  29. Franchi-Gazzola, R.; Visigalli, R.; Dall’Asta, V.; Sala, R.; Woo, S.K.; Kwon, H.M.; Gazzola, G.C.; Bussolati, O. Amino acid depletion activates tonebp and sodium-coupled inositol transport. Am. J. Physiol. Cell Physiol. 2001, 280, C1465–C1474. [Google Scholar] [CrossRef]
  30. Dall’asta, V.; Franchi-Gazzola, R.; Bussolati, O.; Sala, R.; Rotoli, B.M.; Rossi, P.A.; Uggeri, J.; Belletti, S.; Visigalli, R.; Gazzola, G.C. Emerging roles for sodium dependent amino acid transport in mesenchymal cells. Amino Acids 1996, 11, 117–133. [Google Scholar]
  31. Nicklin, P.; Bergman, P.; Zhang, B.; Triantafellow, E.; Wang, H.; Nyfeler, B.; Yang, H.; Hild, M.; Kung, C.; Wilson, C.; et al. Bidirectional transport of amino acids regulates mtor and autophagy. Cell 2009, 136, 521–534. [Google Scholar] [CrossRef] [Green Version]
  32. Timmerman, L.A.; Holton, T.; Yuneva, M.; Louie, R.J.; Padro, M.; Daemen, A.; Hu, M.; Chan, D.A.; Ethier, S.P.; van ‘t Veer, L.J.; et al. Glutamine sensitivity analysis identifies the xct antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell 2013, 24, 450–465. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Franchi-Gazzola, R.; Dall’Asta, V.; Sala, R.; Visigalli, R.; Bevilacqua, E.; Gaccioli, F.; Gazzola, G.C.; Bussolati, O. The role of the neutral amino acid transporter snat2 in cell volume regulation. Acta Physiol. 2006, 187, 273–283. [Google Scholar] [CrossRef] [PubMed]
  34. Hoffmann, T.M.; Cwiklinski, E.; Shah, D.S.; Stretton, C.; Hyde, R.; Taylor, P.M.; Hundal, H.S. Effects of sodium and amino acid substrate availability upon the expression and stability of the snat2 (slc38a2) amino acid transporter. Front. Pharmacol. 2018, 9, 63. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Gaccioli, F.; Huang, C.C.; Wang, C.; Bevilacqua, E.; Franchi-Gazzola, R.; Gazzola, G.C.; Bussolati, O.; Snider, M.D.; Hatzoglou, M. Amino acid starvation induces the snat2 neutral amino acid transporter by a mechanism that involves eukaryotic initiation factor 2alpha phosphorylation and cap-independent translation. J. Biol. Chem. 2006, 281, 17929–17940. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Sengupta, S.; Park, S.H.; Patel, A.; Carn, J.; Lee, K.; Kaplan, D.L. Hypoxia and amino acid supplementation synergistically promote the osteogenesis of human mesenchymal stem cells on silk protein scaffolds. Tissue Eng. Part A 2010, 16, 3623–3634. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Comes, S.; Gagliardi, M.; Laprano, N.; Fico, A.; Cimmino, A.; Palamidessi, A.; De Cesare, D.; De Falco, S.; Angelini, C.; Scita, G.; et al. L-proline induces a mesenchymal-like invasive program in embryonic stem cells by remodeling h3k9 and h3k36 methylation. Stem Cell Rep. 2013, 1, 307–321. [Google Scholar] [CrossRef] [Green Version]
  38. D’Aniello, C.; Fico, A.; Casalino, L.; Guardiola, O.; Di Napoli, G.; Cermola, F.; De Cesare, D.; Tate, R.; Cobellis, G.; Patriarca, E.J.; et al. A novel autoregulatory loop between the gcn2-atf4 pathway and (l)-proline [corrected] metabolism controls stem cell identity. Cell Death Differ. 2015, 22, 1094–1105. [Google Scholar] [CrossRef]
  39. Yi, X.; Liu, J.; Wu, P.; Gong, Y.; Xu, X.; Li, W. The whole transcriptional profiling of cellular metabolism during adipogenesis from hmscs. J. Cell. Physiol. 2020, 235, 349–363. [Google Scholar] [CrossRef]
  40. Meier, C.; Camargo, S.M.; Hunziker, S.; Moehrlen, U.; Gros, S.J.; Bode, P.; Leu, S.; Meuli, M.; Holland-Cunz, S.; Verrey, F.; et al. Intestinal imino transporter sit1 is not expressed in human newborns. Am. J. Physiol. Gastrointest. Liver Physiol. 2018, 315, G887–G895. [Google Scholar] [CrossRef]
  41. Andre, V.; Longoni, D.; Bresolin, S.; Cappuzzello, C.; Dander, E.; Galbiati, M.; Bugarin, C.; Di Meglio, A.; Nicolis, E.; Maserati, E.; et al. Mesenchymal stem cells from shwachman-diamond syndrome patients display normal functions and do not contribute to hematological defects. Blood Cancer J. 2012, 2, e94. [Google Scholar] [CrossRef]
  42. Bustin, S.A. Absolute quantification of mrna using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 2000, 25, 169–193. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Chiu, M.; Taurino, G.; Bianchi, M.G.; Ottaviani, L.; Andreoli, R.; Ciociola, T.; Lagrasta, C.A.M.; Tardito, S.; Bussolati, O. Oligodendroglioma cells lack glutamine synthetase and are auxotrophic for glutamine, but do not depend on glutamine anaplerosis for growth. Int. J. Mol. Sci. 2018, 19, 1099. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Ijms 21 01899 g001 550
Figure 1. System A activity is negligible in human mesenchymal stem cells. (a) The 1-min uptake of 3H-Gln (0.1 mM, 10 μCi/mL) in IMR-90 fibroblasts, MSC and hTERT-MSC after a 90-min incubation in amino acid-free EBSS. Gln uptake was performed in EBSS in the absence (-) or in the presence of MeAIB (10 mM), threonine (Thr, 5 mM) or histidine (His, 5 mM), or in Na+-free EBSS. The Na+-dependent fraction was calculated by subtracting the uptake in the absence of Na+ from the Gln uptake determined in the presence of the cation under the same conditions. Data are expressed as pmol/mg prot/min and are means ± SD of two experiments, with five independent determinations each. (b) Intracellular Gln content in IMR-90 fibroblasts, MSC and hTERT-MSC maintained in normal growth medium. Data are expressed as nmol/mg prot and are means ± SD of two experiments with three independent determinations each. For MSC, data are the means of the data obtained from two different donors. For (a) and (b) * p < 0.05, ** p < 0.01, *** p < 0.001, as assessed with two-tailed Student’s t-tests.
Figure 1. System A activity is negligible in human mesenchymal stem cells. (a) The 1-min uptake of 3H-Gln (0.1 mM, 10 μCi/mL) in IMR-90 fibroblasts, MSC and hTERT-MSC after a 90-min incubation in amino acid-free EBSS. Gln uptake was performed in EBSS in the absence (-) or in the presence of MeAIB (10 mM), threonine (Thr, 5 mM) or histidine (His, 5 mM), or in Na+-free EBSS. The Na+-dependent fraction was calculated by subtracting the uptake in the absence of Na+ from the Gln uptake determined in the presence of the cation under the same conditions. Data are expressed as pmol/mg prot/min and are means ± SD of two experiments, with five independent determinations each. (b) Intracellular Gln content in IMR-90 fibroblasts, MSC and hTERT-MSC maintained in normal growth medium. Data are expressed as nmol/mg prot and are means ± SD of two experiments with three independent determinations each. For MSC, data are the means of the data obtained from two different donors. For (a) and (b) * p < 0.05, ** p < 0.01, *** p < 0.001, as assessed with two-tailed Student’s t-tests.
Ijms 21 01899 g001
Ijms 21 01899 g002 550
Figure 2. Expression of SNAT1 and SNAT2 in human fibroblasts and mesenchymal stem cells. (a,b) SLC38A1 (a) and SCL38A2 (b) mRNA expression was assessed by real-time PCR in IMR-90 fibroblasts, MSC and hTERT-MSC incubated in standard growth medium (empty bars) or in amino acid-free EBSS (gray bars). Data were normalized to the expression of RPL-15. For MSC, data were derived from cells of three different donors. Data are presented as means ± SD of two experiments with two independent determinations each. * p < 0.05, *** p < 0.001 vs. IMR-90 and $ p < 0.05, $$$ p < 0.001 vs. each control, as assessed with two-tailed Student’s t-tests.
Figure 2. Expression of SNAT1 and SNAT2 in human fibroblasts and mesenchymal stem cells. (a,b) SLC38A1 (a) and SCL38A2 (b) mRNA expression was assessed by real-time PCR in IMR-90 fibroblasts, MSC and hTERT-MSC incubated in standard growth medium (empty bars) or in amino acid-free EBSS (gray bars). Data were normalized to the expression of RPL-15. For MSC, data were derived from cells of three different donors. Data are presented as means ± SD of two experiments with two independent determinations each. * p < 0.05, *** p < 0.001 vs. IMR-90 and $ p < 0.05, $$$ p < 0.001 vs. each control, as assessed with two-tailed Student’s t-tests.
Ijms 21 01899 g002
Ijms 21 01899 g003 550
Figure 3. Mesenchymal stem cells have a lower membrane expression of SNAT1 and SNAT2. (a,b) Immunofluorescence of SNAT2 (red), SNAT1 (green) and actin (white) in IMR-90, MSC and hTERT-MSC incubated in complete growth medium (a) or in amino acid-free EBSS for 4 h (b). Single confocal sections of representative fields are shown. Bar = 20 μm.
Figure 3. Mesenchymal stem cells have a lower membrane expression of SNAT1 and SNAT2. (a,b) Immunofluorescence of SNAT2 (red), SNAT1 (green) and actin (white) in IMR-90, MSC and hTERT-MSC incubated in complete growth medium (a) or in amino acid-free EBSS for 4 h (b). Single confocal sections of representative fields are shown. Bar = 20 μm.
Ijms 21 01899 g003
Ijms 21 01899 g004 550
Figure 4. Marginal stimulation of System A activity in amino acid-starved human mesenchymal stem cells. (a–c) The 1-min uptake of 14C-MeAIB (0.1 mM, 2.5 μCi/mL) in IMR-90 fibroblasts, three strains of primary MSC and hTERT-MSC after a 90-min (a) or a 4-h (b) incubation in amino acid-free EBSS. MeAIB uptake was performed in EBSS in the absence (-Na+) or in the presence of sodium (+Na+). The Na+-dependent fraction (c) was calculated by subtracting the uptake in the absence of Na+ from the MeAIB uptake determined in the presence of the cation at the same time of incubation in EBSS. Data are expressed as pmol/mg prot/min and are means ± SD of two experiments, with five independent determinations each. * p < 0.05, ** p < 0.01, *** p < 0.001, as assessed with two-tailed Student’s t-tests.
Figure 4. Marginal stimulation of System A activity in amino acid-starved human mesenchymal stem cells. (a–c) The 1-min uptake of 14C-MeAIB (0.1 mM, 2.5 μCi/mL) in IMR-90 fibroblasts, three strains of primary MSC and hTERT-MSC after a 90-min (a) or a 4-h (b) incubation in amino acid-free EBSS. MeAIB uptake was performed in EBSS in the absence (-Na+) or in the presence of sodium (+Na+). The Na+-dependent fraction (c) was calculated by subtracting the uptake in the absence of Na+ from the MeAIB uptake determined in the presence of the cation at the same time of incubation in EBSS. Data are expressed as pmol/mg prot/min and are means ± SD of two experiments, with five independent determinations each. * p < 0.05, ** p < 0.01, *** p < 0.001, as assessed with two-tailed Student’s t-tests.
Ijms 21 01899 g004
Ijms 21 01899 g005 550
Figure 5. Human mesenchymal stem cells do not accumulate Pro through the activity of sodium-dependent transporters. (a–c) Uptake of 3H-Pro (0.1 mM, 15 μCi/mL) in IMR-90 fibroblasts (a), MSC (b) and hTERT-MSC (c) after a 90-min incubation in amino acid-free EBSS. Data are expressed as pmol/mg prot and are means ± SD of two experiments, with five independent determinations each. * p < 0.05, *** p < 0.001, as assessed with two-tailed Student’s t-tests.
Figure 5. Human mesenchymal stem cells do not accumulate Pro through the activity of sodium-dependent transporters. (a–c) Uptake of 3H-Pro (0.1 mM, 15 μCi/mL) in IMR-90 fibroblasts (a), MSC (b) and hTERT-MSC (c) after a 90-min incubation in amino acid-free EBSS. Data are expressed as pmol/mg prot and are means ± SD of two experiments, with five independent determinations each. * p < 0.05, *** p < 0.001, as assessed with two-tailed Student’s t-tests.
Ijms 21 01899 g005
Ijms 21 01899 g006 550
Figure 6. Human mesenchymal stem cells do not restore cell volume upon hypertonic stress. The 10-min distribution of 14C-Urea (0.5 mM, 10 μCi/mL) in IMR-90 fibroblasts, primary MSC and hTERT-MSC after a 3 h incubation with an isotonic (300 mOsm) or hypertonic medium (450 mOsm). Data are expressed as µL/mg prot and are means ± SD of two experiments, with three independent determinations each. * p < 0.05, ** p < 0.01, as assessed with two-tailed Student’s t-tests.
Figure 6. Human mesenchymal stem cells do not restore cell volume upon hypertonic stress. The 10-min distribution of 14C-Urea (0.5 mM, 10 μCi/mL) in IMR-90 fibroblasts, primary MSC and hTERT-MSC after a 3 h incubation with an isotonic (300 mOsm) or hypertonic medium (450 mOsm). Data are expressed as µL/mg prot and are means ± SD of two experiments, with three independent determinations each. * p < 0.05, ** p < 0.01, as assessed with two-tailed Student’s t-tests.
Ijms 21 01899 g006

Share and Cite

MDPI and ACS Style

Chiu, M.; Taurino, G.; Bianchi, M.G.; Dander, E.; Fallati, A.; Giuliani, N.; D’Amico, G.; Bussolati, O. Functional Consequences of Low Activity of Transport System A for Neutral Amino Acids in Human Bone Marrow Mesenchymal Stem Cells. Int. J. Mol. Sci. 2020, 21, 1899. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21051899

AMA Style

Chiu M, Taurino G, Bianchi MG, Dander E, Fallati A, Giuliani N, D’Amico G, Bussolati O. Functional Consequences of Low Activity of Transport System A for Neutral Amino Acids in Human Bone Marrow Mesenchymal Stem Cells. International Journal of Molecular Sciences. 2020; 21(5):1899. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21051899

Chicago/Turabian Style

Chiu, Martina, Giuseppe Taurino, Massimiliano G. Bianchi, Erica Dander, Alessandra Fallati, Nicola Giuliani, Giovanna D’Amico, and Ovidio Bussolati. 2020. "Functional Consequences of Low Activity of Transport System A for Neutral Amino Acids in Human Bone Marrow Mesenchymal Stem Cells" International Journal of Molecular Sciences 21, no. 5: 1899. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21051899

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop